Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

被引：4
|
作者：
Kucharz, Eugeniusz Jozef [1 ]
Kotulska-Kucharz, Anna [1 ]
机构：
[1] Med Univ Silesia, Dept Internal Med Rheumatol & Clin Immunol, 45-47 Ziolowa St, PL-40635 Katowice, Poland
来源：
REUMATOLOGIA | 2021年 / 59卷 / 02期
关键词：
D O I：
10.5114/reum.2021.105438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：65 / 67
页数：3
相关论文
共 50 条
  • [21] TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Ubago, R.
    Castillo, M. A.
    Marin, R.
    Flores, S.
    Rodriguez, R.
    VALUE IN HEALTH, 2011, 14 (07) : A302 - A302
  • [22] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [23] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
    Sener, Seher
    Basaran, Ozge
    Bilginer, Yelda
    Kiper, Nural
    Ozen, Seza
    PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
  • [24] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [25] Tumor necrosis factor alpha
    Haywood, LJ
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1998, 90 (03) : 129 - 129
  • [26] Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure
    Jiang, Yan
    Lin, Oliver
    Sinha, Sidhartha R.
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1597 - 1606
  • [27] THE USE OF TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR INFLAMMATORY BOWEL DISEASE PATIENTS WITH CONCURRENT HEART FAILURE
    Jiang, Yan
    Lin, Oliver N.
    Sinha, Sidhartha R.
    GASTROENTEROLOGY, 2017, 152 (05) : S584 - S584
  • [28] Dermatoses in patients with inflammatory bowel disease under tumor necrosis factor-alpha inhibitors treatment
    Magalhaes, Carolina Mundim Couto
    Bartholo, Marina Ribeiro
    Correa, Bernardo Henrique Mendes
    Ferrari, Maria de Lourdes Abreu
    Ferrari, Teresa Cristina Abreu
    MEDICINA CLINICA, 2025, 164 (04): : 173 - 177
  • [29] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Jansson-Knodell, Claire L.
    Harris, Courtney E.
    Loftus, Edward V., Jr.
    Walker, Randall C.
    Enzler, Mark J.
    Virk, Abinash
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 190 - 198
  • [30] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Claire L. Jansson-Knodell
    Courtney E. Harris
    Edward V. Loftus
    Randall C. Walker
    Mark J. Enzler
    Abinash Virk
    Digestive Diseases and Sciences, 2021, 66 : 190 - 198
12345